UK-based Tenpoint Therapeutics and Seattle’s Visus Therapeutics have announced the completion of their merger to create an ...

BenevolentAI restructures to focus on modular AI technology and extend its financial runway into 2027. The company may delist ...

US pharma giant Pfizer and Alliance Foundation Trials (AFT) have announced results from the Phase III PATINA trial.

Eli Lilly announces a $15 billion share buyback, three times its previous largest program, highlighting strong financial ...

Danish allergy immunotherapy specialist ALK Abello announced that its European regulatory filing for Acarizax (house dust ...

UK-based Essential Pharma has announced the completion of a 900 million euros ($945 million) financing. The company was ...

USA-based Elevation Oncology, an innovative oncology company focused on the discovery and development of selective cancer ...

Daiichi Sankyo invests $150 million to establish a new antibody-drug conjugate manufacturing facility in Shanghai by 2030, ...

Eli Lilly announces positive Phase III EMBER-3 trial results for imlunestrant in advanced breast cancer, showing a 38% ...

California-based Angitia Biopharmaceuticals, a biotech focused on the discovery and development of innovative therapeutics ...

Chinese biopharma Hutchmed today announced that the Center for Drug Evaluation of China’s National Medical Products ...

Utah, USA-based privately-held biotech Halia Therapeutics has announced promising top-line data resulting in the advancement ...